AGP Picks
View all

West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

Press releases published on September 10, 2026

LifeLabs Celebrates 11 Family Scholarship Recipients for 2026
The Sequoia Project, AHIMA, and HCPro Launch Information Blocking Compliance Training Series Ahead of Active Federal Enforcement
The BodyMind Workout Announces Dr. Desi Bartlett’s New Perimenopause and Midlife Programming Partnership With Glo
Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
Rema Hort Mann Fund Celebrates 30 Years of Art and Care with Milestone Gala and Launch of New Chapter of Expanded Grantmaking with Artists Living with Cancer Grant
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GENFIT annonce sa participation à la  H.C. Wainwright 28th Annual Conference
Aegis Treatment Centers Opens New Medication Location in Long Beach, Expanding Access to Addiction Treatment in Los Angeles County
Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Rad Source Technologies Introduces Sterile Insect Farms™
ACGME Announces Winner of National Nutrition Essay Contest
ダークホース・コンサルティング・グループ、上海オフィスの開設を記念してテープカット式典を開催
Dark Horse Consulting Group 举行剪彩仪式,庆祝上海办公室开业
Dark Horse Consulting Group 舉行剪綵儀式,標誌其上海辦事處正式開業
Dark Horse Consulting Group, 리본 커팅 행사 열고 상하이 사무소 공식 개소
Dark Horse Consulting Group Meraikan Pembukaan Pejabat Baharu di Shanghai dengan Upacara Pemotongan Reben
Renown Health Announces Plans to Build a Children's Hospital for Northern Nevada with $40 Million Gift from Philanthropist Tom Golisano
IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

West Virginia Healthcare Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.